4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-24-056402
Chief Medical Officer acquired 6,730 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mirza Nadeem Q. Chief Medical Officer | 2024-05-01 | Grant or award | +6,730 | 6,730 | D | ||
| Derivatives | |||||||
| Mirza Nadeem Q. Chief Medical Officer | 2024-05-01 | Grant or award · Stock Options (Right to Purchase) | +26,920 | 26,920 | D | ||
Loading xslF345X05/tm2413094-2_4seq1.xml…